Storia in 19 fonti

Hope for melanoma patients: New vaccine trial yields positive results

The first positive results from an mRNA-based cancer therapy for melanoma have been announced by Merck and Moderna, signalling a potential breakthrough in treatment.

Raccontata da

huffpost.com+7 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

iol.co.zaStai leggendo9 h fa

Hope for melanoma patients: New vaccine trial yields positive results

The first positive results from an mRNA-based cancer therapy for melanoma have been announced by Merck and Moderna, signalling a potential breakthrough in treatment.

originale

Timeline cronologica

mercoledì 19 agosto 2026·timesofisrael.com
‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence
News of first positive large late-stage trial result for drug could signal new era for treating solid-tumor cancers, with tests underway for lung, breast and pancreatic cancers
mercoledì 19 agosto 2026·biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…

Hope for melanoma patients: New vaccine trial yields positive results

Confronto fonti

Hope for melanoma patients: New vaccine trial yields positive results

Timeline cronologica

‘Breakthrough’ Moderna personalized mRNA cancer vaccine curbs melanoma reoccurrence

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

New Melanoma Vaccine Shows Promise In Fighting Cancer, Preventing Recurrence

mRNA’s second act: A bespoke cancer vaccine & what Merck-Moderna’s melanoma trial could mean for oncology

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in…

A personalized mRNA therapy passes a phase 3 melanoma trial for the first time

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

mRNA melanoma vaccine-pembrolizumab combo shows survival gains in late-stage trial

A personalized mRNA therapy passes a phase 3 melanoma trial for the first time

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

‘First time’: Drug giants’ cancer breakthrough

Melanoma, nuove speranze da vaccino sperimentale di Moderna e Merck: "Risultati promettenti" - Il Quotidiano del Sud

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…

Melanoma, risultati positivi per il vaccino a mRna (la stessa tecnologia usata contro il Covid) personalizzato

Moderna and Merck shares soar on mRNA cancer vaccine

New Cancer Treatment Hope After mRNA Vaccine Success

Moderna y Merck anuncian el éxito de su vacuna contra el melanoma tras un ensayo con resultados prometedores

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Moderna shares nearly triple on skin cancer vaccine success

New Melanoma Vaccine Shows Promise In Fighting Cancer, Preventing Recurrence

Una vacuna contra el melanoma cerca de ser aprobada

Moderna cancer vaccine stops melanoma returning: what’s next for personalized treatments?

Moderna, Merck breakthrough could usher in a wave of cancer vaccines